Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care

NCT04212390 is registered in ClinicalTrials.gov with Fondazione Italiana Sindromi Mielodisplastiche-ETS as lead sponsor.

NCT NCT04212390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04212390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care
Lead sponsor
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Phase
Observational
Overall status
Completed
Start date
June 3, 2020
Completion date
July 18, 2024
Enrollment
1,000 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mds (myelodysplastic syndrome)